Skip to content
healthcare.dev
Get a free key

LAZCLUZE

NDC 57894-240, lazertinib, tablet, film coated, from Janssen Biotech, Inc..

Product NDC
57894-240
Status
Listed
Labeler
Janssen Biotech, Inc.
Dosage form
TABLET, FILM COATED
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA219008
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/57894-240 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • LAZERTINIB240 mg/1

Pharmacologic classes

Breast Cancer Resistance Protein Inhibitors [MoA]; Cytochrome P450 3A4 Inhibitors [MoA]; Kinase Inhibitor [EPC]; Kinase Inhibitors [MoA]

Package NDCNDC-11Package
57894-240-30578940240301 BOTTLE in 1 CARTON (57894-240-30) / 30 TABLET, FILM COATED in 1 BOTTLE
57894-240-99578940240991 DOSE PACK in 1 CARTON (57894-240-99) / 14 TABLET, FILM COATED in 1 DOSE PACK

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/c417f9ee-2027-4ed5-92ad-3c19266de16c

Use it

Look up 57894-240 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/57894-240 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 57894-240. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.